DNA Script

DNA Script is a pioneer in the field of enzymatic DNA synthesis, offering a benchtop platform (SYNTAX®) that allows researchers to synthesize DNA on-demand within their own labs. This technology addresses a critical bottleneck in synthetic biology by drastically reducing the turnaround time for obtaining synthetic DNA compared to traditional outsourced chemical methods. The company targets a broad customer base including biotech, pharma, CROs, and core facilities, aiming to decentralize and accelerate the pace of discovery. Its expansion through global distributor networks indicates a transition from technology development to commercial scaling.

Proprietary Enzymatic DNA Synthesis (EDS) using engineered Terminal Deoxynucleotidyl Transferase (TdT) and reversibly terminated nucleotides to synthesize high-quality DNA on the benchtop SYNTAX® platform.

DNA Script competes with traditional outsourced DNA synthesis service providers (e.g., Twist Bioscience, Integrated DNA Technologies) and is a leader among a new wave of companies developing enzymatic DNA synthesis platforms (e.g., Molecular Assemblies, Ansa Biotechnologies). It also faces potential competition from large instrument companies (e.g., Danaher, Thermo Fisher) that may develop or acquire similar technology.